Arterial oxygen saturation
Sputum induction is being used increasingly to diagnose respiratory pathogens, particularly Pneumocystis carinii, in HIV positive patients presenting with respiratory symptoms.1-' The procedure may be associated with adverse events, including cough, dyspnoea, nausea, and retching, and some patients find the procedure unpleasant. 4 More serious adverse events include the rapid development of pleural effusions after sputum induction. 5 In this study we 
Results
The diagnoses in the patients in group 2 were cytomegalovirus pneumonitis (1 patient), intrapulmonary lymphoma (1), intrapulmonary Kaposi's sarcoma (1), bacterial pneumonia (3), bronchitis responding to oral erythromycin or amoxycillin (11), self limiting fever and cough with dyspnoea and negative results in investigations (4) .
Eleven patients in group 1 (four smokers)
showed a fall in Sao2 to 92% or less (figure, A).
One patient had sputum induction discontinued when he became dyspnoeic; the Sao2 had fallen to 84% within five minutes of the start of the procedure. In the remaining 10 patients, whose Sao2 fell to 92% or less, the fall usually started five to 10 minutes after the start of the procedure. In two patients the Sao2 began to rise once the procedure was completed but had not returned to baseline 20 minutes later. In the other eight patients a further fall in Sao2 occurred after sputum induction was completed. Four of these patients had mild dyspnoea and an Sao2 of90% or less 20 minutes after the end of sputum induction; these patients were then given supplemental oxygen. Nine patients in group 2 (five smokers) showed a fall in Sao2 to 92% or less during the procedure; in one sputum induction was discontinued because it fell to 84% (after 10 minutes' saline inhalation) and the patient was tachypnoeic and dyspnoeic (figure, B). In the remaining eight patients the fall in Sao2 occurred five to 15 minutes after the start of the procedure. It rose promptly in one patient but in the other seven it fell further after the end of the procedure. Three patients, who had an Sao2 of 89% or less 20 minutes after the procedure, were dyspnoeic and wire given oxygen via a face mask. No control subject had an Sao2 of 92% or less during or after inhalation of hypertonic saline (table) .
Neither the severity of chest radiographic abnormalities nor the A-aDo2 allowed prediction of which patients would develop arterial oxygen desaturation. The range (mean) radiographic score in those who did and did not develop oxygen desaturation was 0-3 (1 6) and 0-3 (1 5). In group 1 in those that did and did not develop oxygen desaturation the range (mean) A-aDo2 was 0-3-7-6 (4 7) and 0A45-8 asthma felt dyspnoeic soon after beginning to inhale saline; his peak flow fell from 610 to 5701/ min but had risen to baseline 30 minutes later. 91-7% in group 1 represents a fall in Pao2 from 10-3 to 8-3 kPa; in group 2 the mean fall from 97% to 93-6% represents a fall from 12-2 to 9 0 kPa.7 There was virtually no change in arterial oxygen saturation in the control group, which suggests that arterial desaturation occurs only in patients with abnormal lungs. Possibly non-HIV infected patients with pulmonary infection would also show a fall in arterial oxygen saturation during sputum induction; alternatively HIV infection, by producing low grade alveolitis, may predispose to desaturation.' Sputum induction in HIV positive patients was safe in this study and no special supervision is needed if the procedure is carried out in a ward with staffnearby. Patients who are hypoxaemic before sputum induction may require more supervision and Sao2 monitoring may be useful during and immediately after the procedure. The persistence of arterial desaturation may be important if other procedures, such as exercise testing (which may induce further desaturation), are carried out soon after sputum induction.
